March2Millions (@March2Millions) header
March2Millions (@March2Millions) profile picture

Disciplined cannabis investor, looking to obtain financial freedom through this exciting and volatile growth sector. Opinions not advice D.Y.D.D.

North of the Border
Joined June 2018
Photo by March2Millions (@March2Millions)Photo by March2Millions (@March2Millions)Photo by March2Millions (@March2Millions)Photo by March2Millions (@March2Millions)Photo by March2Millions (@March2Millions)Photo by March2Millions (@March2Millions)Photo by March2Millions (@March2Millions)Photo by March2Millions (@March2Millions)Photo by March2Millions (@March2Millions)Photo by March2Millions (@March2Millions)
March2Millions retweeted
The #hemp industry spent years telling everybody they weren't selling #weed. Now they're fighting for their right to sell weed 🤣
10
8
48
1,904
Replying to @jamiecampbell
Imagine comparing a broad sector sell off of GTI.. to a 5 month “alpha” investment that’s down 90% outside of the broad basket. 90M of AUM burned
1
11
637
March2Millions retweeted
Onward! 💚
Trulieve Announces Preliminary Addition to the Russell 2000® and 3000® Indices $TRLV investors.trulieve.com/2026-…
17
22
244
4,512
Senator Chris Van Hollen (D-MD), who is challenging Chuck Schumer for Senate majority leader, supports federally descheduling cannabis. Schumer also supports descheduling but never followed through on his promise to hold a vote on this and SAFE during his time as majority leader.
16
20
3
211
4,983
Advisor Shares conduct when it comes to Green Thumb Industries gets sadder by the day. $MSOS $GTII $GTBIF #StocksNotSwaps #BuyTheUnderlyings #AnyAdultsInTheRoom ?
So you made up a delisting rumor based on a complete lack of due diligence? 1) they are exiting the hemp business should the ban go through 2) they have a much larger licensing revenue segment unrelated to hemp that will continue. Delisting is not even on the table
4
1
29
1,835
March2Millions retweeted
Discipline is boring. Hard work is boring. Studying is boring. Doing the same thing every day is boring. As a man who wants to go far in life, learn to be bored, silent, and alone.
42
463
8
3,284
65,104
$MSOS leaderships justification for actively selling $GTBIF to increase their $GLAS position -90% ago #StocksNOTswaps #BuyTheUnderlyings
Replying to @bchapm11
Depending on who you ask, they are all bad companies.
3
2
1
41
2,558
March2Millions retweeted
🚨 UPDATE: Trulieve Cannabis @Trulieve @Trulieve_IR (NYSE: $TRLV) has been added to FTSE Russell’s preliminary additions list for the Russell 3000 as part of the December 2026 reconstitution. This follows Rank Day on October 30. The preliminary list was published after the close today (November 13). Changes take effect after the close on December 11, with trading opening under the new membership on December 14. **Why it matters:** Index funds tracking the Russell 2000 and 3000 (including $IWM, with roughly $78B in assets) would become forced buyers. Prior estimates pointed to 10–15 million shares of demand—about 6–9% of Trulieve’s ~162 million share float—on top of ongoing buybacks. That is material relative to typical volume and should improve liquidity. **Context:** This is the next milestone after Trulieve’s historic June 10 NYSE listing (the first major U.S. plant-touching cannabis company) and its September additions to the S&P Total Market Index, S&P Completion Index, and related health-care sub-indices. Those followed its Delaware domestication and the federal rescheduling of state-licensed medical marijuana to Schedule III, which also enabled DEA registrations. As the largest U.S. medical cannabis operator and roughly 37% of the MSOS ETF, Russell inclusion would expand the passive ownership base and serve as a template for other operators that clear similar eligibility screens. Updates to the preliminary list are expected on November 20, 27, and December 4 before the reconstitution locks in.
🏖️ Trulieve Cannabis @Trulieve @Trulieve_IR (NYSE: $TRLV) is already drawing passive money from broad U.S. market and small-cap index products after its historic NYSE listing and S&P inclusion. 🚨 Tonight, after the close, investors find out whether the pure-play medical cannabis operator joins the Russell 2000 — potentially unlocking a new wave of mandatory buying in a sector still dominated by OTC trading and waiting on fuller federal normalization. Trulieve, the first major plant-touching U.S. cannabis multi-state operator to list on the NYSE (June 2026) after medical marijuana’s rescheduling to Schedule III, was added in September to the S&P Total Market Index, S&P Completion Index, and related health-care sub-indices. That opened the door to passive ownership by funds tracking those benchmarks. Index funds and ETFs already holding ~$60M TRLV Holdings data show a mix of thematic cannabis vehicles and passive broad-market/small-cap products: - AdvisorShares Pure US Cannabis ETF ($MSOS): The largest disclosed holder, with roughly 15% of TRLV’s shares outstanding and a ~23% weighting in the fund itself (MSOS AUM in the high hundreds of millions). This is active/thematic exposure rather than pure index tracking. - Vanguard Extended Market ETF ($VXF) and Vanguard Total Stock Market ETF (VTI): Direct beneficiaries of the S&P Completion and Total Market additions; together they account for a meaningful slice of the passive ownership. - Schwab U.S. Small-Cap ETF ($SCHA) and Schwab U.S. Broad Market ETF ($SCHB) - iShares Core S&P Total U.S. Stock Market ETF ($ITOT) - First Trust small-cap AlphaDEX funds ($FYC, $FYX) and a handful of smaller or multi-cap products. Collectively, tracked ETFs report ownership in the high teens percent of shares (hundreds of millions in value), with Vanguard products alone representing about 2%. These positions largely stem from the post-NYSE/S&P eligibility rather than Russell membership. Pure Russell 2000 trackers such as the iShares Russell 2000 ETF ($IWM, ~$77–78 billion AUM) and Vanguard’s Russell 2000 vehicle ($VTWO) do not yet hold TRLV at scale because it is not currently a constituent. How to find out today after the close FTSE Russell’s December 2026 reconstitution schedule is clear: Rank Day was October 30. Preliminary additions and deletions are published after the U.S. market close today, Friday, November 13. A query period follows (roughly November 16–27), with updates and a lockdown later in the month. Changes take effect after the close on December 11, with markets opening December 14 under the new membership. Check the FTSE Russell / LSEG site (russell-reconstitution resources and notices), major newswires, or company channels after 4 p.m. ET. Some quantitative shops and specialist commentators have flagged TRLV as having cleared the key screens (exchange listing, U.S. domicile after Delaware domestication, float, size, etc.), but the official preliminary list is the confirmation. Estimates from those analyses suggest that full inclusion could require index funds to buy on the order of 10–15 million shares around the reconstitution window—material relative to typical daily volume.[](>) Why this matters for cannabis Most of the cannabis sector still trades on the OTC with limited institutional participation. Federal Schedule I status historically created custody, banking, exchange-listing, and mandate barriers; even after Schedule III rescheduling enabled NYSE listing and S&P eligibility for pure medical operators like Trulieve (which spun out mixed-use assets), many institutions remain cautious pending further clarity on banking (e.g., SAFER-type legislation), adult-use policy, and tax treatment. Index inclusion changes the calculus: • Forced buying: Assets benchmarked to the Russell 2000 ($IWM alone is ~$77–78B; total tracking assets are substantially larger across ETFs and mutual funds) must own the stock in proportion to its index weight once it is added. That creates non-discretionary demand and improved liquidity. • Visibility and cost of capital: Higher trading volume, tighter spreads, and broader ownership can lower the cost of equity and make the stock more investable for managers who previously could not or would not touch OTC cannabis names. • Template effect: As the top holding in $MSOS and a scaled medical operator with strong Florida and other state positions, strong cash generation, and recent DEA registration progress, $TRLV ’s path (NYSE + S&P + potential Russell) is being watched as a blueprint for other larger MSOs once they clear similar eligibility hurdles. • Still early: Even with Schedule III, the sector has not yet seen full institutionalization. Index buying is a meaningful incremental step while the industry continues to wait for broader rescheduling effects, banking access, and clearer federal frameworks. It does not remove operational or regulatory risks, but it does expand the buyer base beyond retail and specialized cannabis funds. In short, today’s after-close preliminary list is the next concrete data point in cannabis’s gradual move from OTC niche to mainstream small-cap index eligibility. Confirmation of Russell 2000 addition would mark another milestone in that process; absence would simply mean the company remains outside that particular passive bucket for now while it continues to benefit from the S&P Total Market/Completion ownership already in place. 🇺🇸🌿🧺 $MSOS
12
21
6
107
7,794
A new spending bill released by the U.S. Senate Appropriations Committee would extend federal protections for medical marijuana patients and businesses through September 2027, covering 48 states, D.C., and four U.S. territories. themarijuanaherald.com/2026/…
4
10
2
61
7,039
March2Millions retweeted
RIP intoxicating hemp derived synthetics. 11/12/2026. $MSOS
18
9
2
164
19,526
A former Trump official just alleged that former White House Chief of Staff Susie Wiles interfered in hemp policy. Her son-in-law has led an industry campaign to block federal restrictions. We FOIAed Wiles’ communications with the White House on the topic. politico.com/news/2026/11/10…
11
135
10
284
23,840
March2Millions retweeted
Replying to @sammyj_19
@sammyj_19 brings up a good point. Here's revenue growth relative to weighted average shares-diluted: -GTI: +18.9% -Cura: +6.8% -Jushi: +5.7% -Terrascend: +3.9% -Verano: +3.7% -Cresco: -0.1% -Trul: -0.7%
Replying to @CannaVestments
Thanks, N. How about on a per share basis? We need to start thinking in terms of growth per share, since that is what actually matters most.
5
6
3
58
4,267
March2Millions retweeted
Susie Wiles son in law is one of the largest gas station synthetic Cannabinoid (THCP) peddling providers in the country. This is a bipartisan issue. No one wants untested synthetics cannabinoids that are 33X more potent than THC yet sold at gas stations with lower safety testing standards than highly regulated dispensaries. @TheDankInformer has the receipts. @joeroganhq @RandPaul
36
423
18
1,401
50,968
March2Millions retweeted
EXCLUSIVE: Bret Worley, son-in-law of White House Chief of Staff Susie Wiles and husband of Caroline Wiles, is accused in a federal lawsuit of boasting that his political connections could secure appointments and favors. Worley is reportedly close with Morgan DeWitt-Snow, Deputy Director of the White House Presidential Personnel Office (PPO), which oversees political appointments across the administration. The lawsuit alleges Worley claimed he could leverage his relationship with Wiles to advance his business interests and political influence. Worley’s hemp companies were previously hit with $125,000 in Colorado settlement penalties in 2025 and 2026, with Colorado Attorney General Phil Weiser calling it “shameful” that the companies were caught twice engaging in deceptive practices. Follow: @AFpost
115
541
91
1,458
260,213
March2Millions retweeted
Stephen Miller has been named Trump's next White House chief of staff. Although Miller initially opposed marijuana rescheduling, sources say he's since come around to the idea, and his wife, Katie Miller, hosted Mike Tyson on her podcast in September 2025 to discuss rescheduling.
15
23
3
187
52,292
March2Millions retweeted
Illinois Gov. JB Pritzker (D), Lt. Gov. Juliana Stratton (D) and U.S. Sen. Tammy Duckworth (D-IL) published a congressional agenda calling for the federal recriminalization of hemp THC products to take effect without additional delay and telling lawmakers to "not further regulate or legalize intoxicating hemp." "Continued sales also undercut Illinois’ licensed cannabis businesses and the social equity businesses at the core of its cannabis industry." marijuanamoment.net/illinois…
23
13
10
40
17,874